Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primer. 2020;6:92.

Article  Google Scholar 

Karemore P, Jayaprakash JP, Narayan KP, Khandelia P. Regulatory crosstalk between TGF-β signaling and miRNAs: a head and neck cancer perspective. The Nucleus [Internet]. 2024 [cited 2024 Sep 24]; Available from: https://doi.org/10.1007/s13237-024-00499-x

Patini R, Favetti Giaquinto E, Gioco G, Castagnola R, Perrotti V, Rupe C, et al. Malnutrition as a risk factor in the development of oral cancer: a systematic literature review and meta-analyses. Nutrients. 2024;16:360.

Article  PubMed  PubMed Central  Google Scholar 

Sun Z, Sun X, Chen Z, Du J, Wu Y. Head and neck squamous cell carcinoma: risk factors, molecular alterations, immunology and peptide vaccines. Int J Pept Res Ther. 2022;28:19.

Article  CAS  PubMed  Google Scholar 

Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15:44.

Article  PubMed  PubMed Central  Google Scholar 

Shah AB, Nagalli S. Nasopharyngeal Carcinoma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554588/

Zhang Q, Wang H, Zhao Q, Zhang Y, Zheng Z, Liu S, et al. Evaluation of risk factors for laryngeal squamous cell carcinoma: a single-center retrospective study. Front Oncol. 2021;11:606010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders O, Pathak S. Hypopharyngeal Cancer. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK567720/

Liu H, Wang Y, Xue T, Yang Z, Kan S, Hao M, et al. Roles of m6A modification in oral cancer (Review). Int J Oncol. 2022;62:5.

Article  PubMed  PubMed Central  Google Scholar 

Arzumanian VA, Dolgalev GV, Kurbatov IY, Kiseleva OI, Poverennaya EV. Epitranscriptome: review of top 25 most-studied RNA modifications. Int J Mol Sci. 2022;23:13851.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jalan A, Jayasree PJ, Karemore P, Narayan KP, Khandelia P. Decoding the “fifth” nucleotide: impact of RNA pseudouridylation on gene expression and human disease. Mol Biotechnol. 2023;66:1581.

Article  PubMed  Google Scholar 

Karthiya R, Wasil SM, Khandelia P. Emerging role of N4-acetylcytidine modification of RNA in gene regulation and cellular functions. Mol Biol Rep. 2020;47:9189–99.

Article  CAS  PubMed  Google Scholar 

Wilkinson E, Cui Y-H, He Y-Y. Roles of RNA Modifications in Diverse Cellular Functions. Front Cell Dev Biol [Internet]. 2022 [cited 2024 Apr 13];10. Available from: https://www.frontiersin.org/articles/https://doi.org/10.3389/fcell.2022.828683

Chen Y, Jiang X, Li X, Yan D, Liu J, Yang J, et al. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma. Ann Transl Med. 2021;9:1346.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karthiya R, Khandelia P. m6A RNA Methylation: ramifications for gene expression and human health. Mol Biotechnol. 2020;62:467–84.

Article  CAS  PubMed  Google Scholar 

Jing F-Y, Zhou L-M, Ning Y-J, Wang X-J, Zhu Y-M. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review. Front Cell Dev Biol [Internet]. 2021 [cited 2024 Feb 2];9. Available from: https://www.frontiersin.org/articles/https://doi.org/10.3389/fcell.2021.683254

Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.

Article  CAS  PubMed  Google Scholar 

Zhai Y, Zheng L. m6A RNA methylation regulator-related signatures exhibit good prognosis prediction ability for head and neck squamous cell carcinoma. Sci Rep. 2022;12:16358.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai H, Liang J, Jiang Y, Tan R, Hou C, Hou J. Integrative analysis of N6-methyladenosine-related enhancer RNAs identifies distinct prognosis and tumor immune micro-environment patterns in head and neck squamous cell carcinoma. Cancers. 2022;14:4657.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sağlam B, Akgül B. An overview of current detection methods for RNA methylation. Int J Mol Sci. 2024;25:3098.

Article  PubMed  PubMed Central  Google Scholar 

Goh WSS, Kuang Y. Heterogeneity of chemical modifications on RNA. Biophys Rev [Internet]. 2023 [cited 2023 Oct 21]; Available from: https://doi.org/10.1007/s12551-023-01128-8

Ye H, Li T, Rigden DJ, Wei Z. m6ACali: machine learning-powered calibration for accurate m6A detection in MeRIP-Seq. Nucleic Acids Res. 2024;52:4830–42.

Article  PubMed  PubMed Central  Google Scholar 

Hu C, Liu J, Li Y, Jiang W, Ji D, Liu W, et al. Multifaceted roles of the N6-methyladenosine RNA methyltransferase METTL3 in cancer and immune microenvironment. Biomolecules. 2022;12:1042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93–5.

Article  CAS  PubMed  Google Scholar 

Wu S, Makeudom A, Sun X, Li X, Xu D, Sastraruji T, et al. Overexpression of methyltransferase-like 3 and 14 in oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2022;51:134–45.

CAS  Google Scholar 

Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, et al. METTL3 promotes tumorigenesis and metastasis through BMI1 m6A methylation in oral squamous cell carcinoma. Mol Ther J Am Soc Gene Ther. 2020;28:2177–90.

Article  CAS  Google Scholar 

Xu L, Li Q, Wang Y, Wang L, Guo Y, Yang R, et al. m6A methyltransferase METTL3 promotes oral squamous cell carcinoma progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA stability. Am J Cancer Res. 2021;11:5282–98.

CAS  PubMed  PubMed Central  Google Scholar 

Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, et al. METTL3 intensifies the progress of oral squamous cell carcinoma via modulating the m6A amount of PRMT5 and PD-L1. J Immunol Res. 2021;2021:6149558.

Article  PubMed  PubMed Central  Google Scholar 

Xu T, Zhang W, Chai L, Liu C, Zhang S, Xu T. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38. Oral Dis. 2023;29:639–48.

Article  PubMed  Google Scholar 

Zhao W, Cui Y, Liu L, Ma X, Qi X, Wang Y, et al. METTL3 facilitates oral squamous cell carcinoma tumorigenesis by enhancing c-Myc stability via YTHDF1-mediated m6A modification. Mol Ther Nucleic Acids. 2020;20:1–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Li H, Yang Z, Liu R, Li Y, Hu Y, et al. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification. Cell Death Dis. 2024;15:1–13.

Article  CAS  Google Scholar 

Chen J, Li S, Huang Z, Cao C, Wang A, He Q. METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma. Cancer Cell Int. 2022;22:295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Zhao T, Zheng S, Tang D, Han H, Yang C, et al. METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC. Oral Dis [Internet]. [cited 2024 Mar 19];n/a. Available from: https://onlinelibrary.wiley.com/doi/abs/https://doi.org/10.1111/odi.14864

Lv R, Yao Y, Dong J, Chen Q. COL1A1, mediated by m6A methylation of METTL3, facilitates oral squamous cell carcinoma cell growth and metastasis. Odontology. 2024. https://doi.org/10.1007/s10266-024-00962-w.

Article  PubMed  Google Scholar 

Chen Z, Chen J, Xu X, Li Q, Zhang C, Li S, et al. METTL3-mediated ALDH m6 a methylation regulates the malignant behavior of BMI1+ HNSCC stem cells. Oral Dis [Internet]. 2023 [cited 2024 Feb 23]; Available from: https://eurekamag.com/research/090/257/090257692.php

Guo Y-Q, Wang Q, Wang J-G, Gu Y-J, Song P-P, Wang S-Y, et al. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression. Exp Hematol Oncol. 2022;11:14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Huang Q, Wu C, Xu Y, Guo Y, Yuan X, et al. m6A-modified HOXC10 promotes HNSCC progression via co-activation of ADAM17/EGFR and Wnt/β-catenin signaling. Int J Oncol. 2023;64:10.